Focus on paroxetine
- 1 January 2003
- journal article
- Published by Taylor & Francis in Current Medical Research and Opinion
- Vol. 19 (1) , 13-21
- https://doi.org/10.1185/030079902125001353
Abstract
This review of paroxetine is based on Medline and PsycLit searches and a manual search of the available research literature. It aims to cover the pharmacology of this frequently prescribed SSRI antidepressant in terms of its indications, efficacy and adverse effects. Overall, paroxetine is a well-tolerated and safe first-line SSRI antidepressant with anxiolytic qualities. It has been found useful in depression, anxiety and other conditions such as obsessive compulsive disorder and post-traumatic stress disorder. The antidepressant has some advantages over earlier tricyclic medication in terms of a lack of cardiovascular side-effects and relative safety in overdose. Cessation of use, however, is associated with withdrawal or discontinuation symptoms and patients should be counselled as to how these might be avoided. A 3- or 4-week graded withdrawal regimen, perhaps with concomitant fluoxetine to cover serotonergic discontinuation symptoms, may be advisable.Keywords
This publication has 63 references indexed in Scilit:
- A meta-analysis of the efficacy and tolerability of paroxetine versus tricyclic antidepressants in the treatment of major depressionInternational Clinical Psychopharmacology, 2001
- Paroxetine Pharmacokinetics in Depressed Children and AdolescentsJournal of the American Academy of Child & Adolescent Psychiatry, 1999
- A double-blind comparison of the efficacy and safety of paroxetine and imipramine in the treatment of depression with dementiaInternational Journal of Geriatric Psychiatry, 1998
- Paroxetine in Children With Major Depressive Disorder: An Open TrialJournal of the American Academy of Child & Adolescent Psychiatry, 1997
- Paroxetine and amitriptyline in the treatment of depression in general practiceActa Psychiatrica Scandinavica, 1996
- Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depressionInternational Clinical Psychopharmacology, 1993
- Paroxetine in the Treatment of Elderly Depressed Patients in General PracticeInternational Clinical Psychopharmacology, 1992
- The Anti-anxiety and Anti-agitation Effects of Paroxetine in Depressed PatientsInternational Clinical Psychopharmacology, 1992
- Meta‐analysis of early phase I1 studies with paroxetine in hospitalized depressed patientsActa Psychiatrica Scandinavica, 1989
- Paroxetine in the treatment of depression ‐ a randomized comparison with amitriptylineActa Psychiatrica Scandinavica, 1985